38 results
8-K
DYAI
Dyadic International Inc., DE
12 Apr 23
Dyadic Announces Expanded Licensing Agreement to Develop and Commercialize Vaccines and Biologics for African Continent
8:30am
will convert into an exclusive license to manufacture bulk materials in the Southern African Development Community (“SADC”). Rubic will pay Dyadic
8-K
EX-10.1
DYAI
Dyadic International Inc., DE
12 Apr 23
Dyadic Announces Expanded Licensing Agreement to Develop and Commercialize Vaccines and Biologics for African Continent
8:30am
to a regulatory approval specific to such condition.
“SADC” means the Southern African Development Community, a regional economic community, which
8-K
EX-99.1
7fwu s2ii
13 Sep 22
Dyadic Updates Market On Recent Scientific Achievements
8:30am
8-K
EX-10.1
j6z65w
27 Jul 21
Entry into a Material Definitive Agreement
8:33am
8-K
EX-99.1
mko67
13 Aug 20
Dyadic Announces Second Quarter 2020 Results
4:24pm
8-K
EX-10.1
8f80b8wdj4 ffjtr5
29 Jun 20
Entry into a Material Definitive Agreement
8:04am
8-K
EX-99.1
34nqencx
30 Mar 20
Dyadic Reports 2019 Year End Results and Recent Developments
4:46pm
8-K
EX-99.1
92ehu1g0 uvx
13 Aug 19
Results of Operations and Financial Condition
4:29pm
8-K
EX-10.1
pyov71ks7gfvjkr3x
8 May 19
Dyadic Announces Sub-Licensing Agreement with Alphazyme
3:15pm
10-K
0is1943cy7l96b00
27 Mar 19
Annual report
4:30pm
10-12G/A
bii 6bzkm8z1gva5
8 Feb 19
Registration of securities (amended)
5:26pm